Amgen Ranks as Top 25 Dividend Giant with 3.21% Yield

Amgen Inc. has been named a Top 25 "Dividend Giant" by ETF Channel with $32.91B worth of stock held by ETFs and a 3.21% yield. The company has a strong quarterly dividend history and favorable long-term growth rates in key fundamental data points. The annualized dividend is $9.52/share, paid quarterly, with the most recent dividend ex-date on 08/22/2025.

Title: Amgen Inc. Named a Top 25 "Dividend Giant" by ETF Channel

Amgen Inc. has been recognized as a Top 25 "Dividend Giant" by ETF Channel, with $32.91 billion worth of stock held by ETFs and a 3.21% yield. The company's strong quarterly dividend history and favorable long-term growth rates in key fundamental data points have contributed to this distinction.

The annualized dividend for Amgen Inc. is $9.52 per share, paid quarterly. The most recent dividend ex-date was August 22, 2025. Amgen's dividend payout ratio (DPR) is currently at 86.86%, indicating a robust dividend distribution to shareholders.

Institutional investors have shown strong interest in Amgen Inc. Argent Trust Co, for instance, increased its stake in Amgen by 4.4% during the first quarter of 2025, acquiring an additional 1,097 shares and bringing its total holdings to 26,114 shares valued at approximately $8.14 million [2].

Amgen Inc. reported earnings per share (EPS) of $4.90 for the most recent quarter, exceeding analysts' expectations of $4.18 and achieving a revenue increase of 9.4% compared to the previous year. The company's revenue for the quarter was up 9.4% compared to the same quarter last year, reaching $8.15 billion [2].

Research analysts have provided a mixed outlook on Amgen Inc. Mizuho increased their price target on Amgen from $235.00 to $280.00 and gave the company a "neutral" rating. Guggenheim issued a "neutral" rating and a $288.00 price target on the stock. UBS Group raised their price target on Amgen from $315.00 to $326.00 and gave the stock a "neutral" rating. Royal Bank Of Canada reduced their price target on Amgen from $324.00 to $320.00 and set an "outperform" rating on the stock. Citigroup raised their price target on Amgen from $300.00 to $305.00 and gave the stock a "neutral" rating [2].

Amgen Inc. has a market capitalization of $159.64 billion, a PE ratio of 27.09, a PEG ratio of 2.57, and a beta of 0.49. The company has a current ratio of 1.17, a quick ratio of 0.88, and a debt-to-equity ratio of 8.70 [1].

Amgen Inc. has a 1-year low of $253.30 and a 1-year high of $339.17. The company's fifty-day moving average price is $292.04 and its 200-day moving average price is $292.03 [1].

Amgen Inc. has a consensus rating of "Hold" and an average target price of $307.27 [2].

References
[1] https://stockanalysis.com/stocks/amgn/dividend/
[2] https://www.marketbeat.com/instant-alerts/filing-argent-trust-co-acquires-1097-shares-of-amgen-inc-nasdaqamgn-2025-08-03/